Drug Profile
PBL 1427
Alternative Names: PBL1427Latest Information Update: 22 Jun 2018
Price :
$50
*
At a glance
- Originator Panacea Biotec
- Class Antihyperglycaemics; Small molecules
- Mechanism of Action Dipeptidyl peptidase 4 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 22 Jun 2018 Panacea Biotec plans a phase I trial in Healthy volunteers in India (CTRI/2017/12/010857)
- 22 Mar 2016 No development reported - Phase-I for Type-2 diabetes mellitus (In volunteers) in India (PO)
- 01 Jul 2012 Phase-I clinical trials in Type-2 diabetes mellitus in India (PO)